Other prediction tools do exist that assess clinical prostate cancer, including AUC measures of PSA to diagnose clinically significant disease [48] and the Gleason score, which has some power to measure prostate cancer aggressiveness and predict treatment outcome [49]. Here, KLK3 is linked to prostate carcinoma.